Episode #13 Drugs & Politics: Is advocating for drug policy reform a political winner?

Episode #13 Drugs & Politics: Is advocating for drug policy reform a political winner?

In this episode, Rob is joined by Ant Lehane, Policy Lead at Cranstoun. Ant has an extensive amount of experience working within the drug policy arena and discussing such topics with politicians from across the UK.

Is advocating for drug policy reform is a vote winner or loser? Which political party boasts the most progressive drug policies within their manifestos? Will we see significant changes to UK drug policy if Labour wins the next general election? Are politicians, behind closed doors, supportive of changing drug laws in the UK? These are just some of the topics discussed in our latest episode.

**Disclaimer. The views and opinions expressed in this episode are those of the panellists and do not necessarily represent those of the organisations they represent and employed by**

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(60)

Developing digital infrastructure within harm reduction with Mark Tudor

Developing digital infrastructure within harm reduction with Mark Tudor

In this episode, we are joined by Mark Tudor, co-founder of Substancy. Mark has worked in the harm reduction field for over 30 years, but most recently has established Substancy, a social enterprise t...

1 Juli 30min

What is trauma-informed practice?

What is trauma-informed practice?

We are joined by Sarah, CAVDAS Alliance Manager, to shed light on what trauma-informed practice is and why it matters. Sarah has led Barod's journey towards becoming a trauma-informed organisation and...

17 Juni 37min

Image and Performance Enhancing Drugs: What's the appeal?

Image and Performance Enhancing Drugs: What's the appeal?

In this episode, we are joined by Liberty Musungo, Image and Performance Enhancing Drugs (IPEDs) Lead for Dyfed Drug and Alcohol Service (DDAS). Liberty takes us through what IPEDs are and how they wo...

2 Juni 45min

How do we become anti-stigma?

How do we become anti-stigma?

In this Learning at Work Week special, we are joined by Barod's Operations Manager, Sian, to discuss how we can move from being non-stigmatising, to actively challenging and becoming anti-stigma.In th...

19 Maj 23min

Inside the Green Party’s Plan to Legalise Drugs

Inside the Green Party’s Plan to Legalise Drugs

In this episode, we are joined by Dr. Carrie Hamilton and Michael Wakelyn-Green, from the Green Party Drug Policy Working Group, to explore the party's proposed approach to drug policy. With recent fo...

21 Apr 43min

Drugs on the brain with Professor David Nutt

Drugs on the brain with Professor David Nutt

In this episode, we’re joined by leading neuropsychopharmacologist, Professor David Nutt, for a deep dive into the human brain and its relationship with drugs. We discuss whether our brains are built ...

25 Mars 54min

The Manifesto Sessions: #9 Enhanced Harm Reduction Centres

The Manifesto Sessions: #9 Enhanced Harm Reduction Centres

**This episode was originally recorded as a webinar on the 17th February 2026**Our 9th webinar within our Manifesto Sessions webinar series focused on Enhanced Harm Reduction Centres (EHRCs). As part ...

13 Mars 54min

Ketamine Assisted Therapy with Lucy da Silva

Ketamine Assisted Therapy with Lucy da Silva

In this episode, we are joined by Lucy da Silva, recognised as one of the UK’s 100 most inspiring businesswomen. Lucy is the co-founder and CEO of Silva Wellness in London, which provides ketamine loz...

25 Feb 42min

Populärt inom Samhälle & Kultur

podme-dokumentar
gynning-berg
p3-dokumentar
svenska-fall
en-mork-historia
tv4-nyheterna-story
creepypodden-med-jack-werner
aftonbladet-krim
badfluence
mardromsgasten
killradet
flashback-forever
hor-har
aftonbladet-daily
kod-katastrof
rss-mer-an-bara-morsa
de-fyras-gang
historiska-brott
rss-sanning-konsekvens
spar